Dados do Trabalho
Título
EVOKE AND EVOKE+: DESIGN OF TWO LARGE-SCALE, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDIES EVALUATING THE NEUROPROTECTIVE EFFECTS OF SEMAGLUTIDE IN EARLY ALZHEIMER’S DISEASE
Palavras-chave
Alzheimer's disease, clinical trials and mild cognitive impairment (MCI)
Área
Cognição
Autores
Alireza Atri, Howard Feldman, Charlotte Hansen, Julie Honore, Peter Johannsen, Filip Knop, Pernille Poulsen, Lars Raket, Mary Sano, Hilkka Soininen, Jeffrey Cummings, Luiz Eduardo Novis